Plant polyphenols and multidrug resistance: Effects of dietary flavonoids on drug transporters in Caco-2 and MDCKII-MDR1 cell transport models

被引:36
作者
Rodriguez-Proteau, R
Mata, JE
Miranda, CL
Fan, Y
Brown, JJ
Buhler, DR
机构
[1] Oregon State Univ, Dept Pharmaceut Sci, Corvallis, OR 97331 USA
[2] Oregon State Univ, Dept Environm & Mol Toxicol, Corvallis, OR 97331 USA
[3] Oregon State Univ, Ctr Environm Hlth Sci, Corvallis, OR 97331 USA
关键词
P-glycoprotein; multidrug resistance; cyclosporin A; digoxin; green tea catechins; xanthohumol;
D O I
10.1080/00498250500433545
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
The hypothesis tested was that specific flavonoids such as epicatechin gallate, epigallocatechin gallate, genistein, genistin, naringenin, naringin, quercetin and xanthohumol will modulate cellular uptake and permeability (P-e) of multidrug-resistant substrates, cyclosporin A (CSA) and digoxin, across Caco-2 and MDCKII-MDR1 cell transport models. H-3-CSA/H-3-digoxin transport and uptake experiments were performed with and without co-exposure of the flavonoids. Aglycone flavonoids reduced the P-e of CSA to a greater extent than glycosylated flavonoids with 30 mu M xanthohumol producing the greatest effect (7.2 x 10(-6) to 6.6 x 10(-7) and 17.9 x 10(-6) to 4.02 x 10(-6) cm s(-1) in Caco-2 and MDCKII-MDR1 cells, respectively); while no measurable effects were seen with digoxin. Xanthohumol significantly demonstrated ( 1) saturable efflux, ( 2) increased uptake of H-3-digoxin and ( 3) decreased uptake of H-3-CSA in the Caco-2 cells. The transport data suggests that xanthohumol effects transport of CSA in a manner that is distinct from the digoxin efflux pathway and suggests that intestinal transport of these MDR1 substrates is more complex than previously reported.
引用
收藏
页码:41 / 58
页数:18
相关论文
共 68 条
[1]
Catechin contents of foods commonly consumed in The Netherlands. 2. Tea, wine, fruit juices, and chocolate milk [J].
Arts, ICW ;
van de Putte, B ;
Hollman, PCH .
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2000, 48 (05) :1752-1757
[2]
Caco-2 monolayers in experimental and theoretical predictions of drug transport (Reprinted from Advanced Drug Delivery Reviews, vol 22, pg 67-84, 1996) [J].
Artursson, P ;
Palm, K ;
Luthman, K .
ADVANCED DRUG DELIVERY REVIEWS, 2001, 46 (1-3) :27-43
[3]
Uptake and transport characteristics of chloroquine in an in-vitro cell culture system of the intestinal mucosa, Caco-2 [J].
Augustijns, PF .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1996, 48 (03) :277-280
[4]
Functional multidrug resistance protein (MRP1) lacking the N-terminal transmembrane domain [J].
Bakos, E ;
Evers, R ;
Szakács, G ;
Tusnády, GE ;
Welker, E ;
Szabó, K ;
de Haas, M ;
van Deemter, L ;
Borst, P ;
Váradi, A ;
Sarkadi, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (48) :32167-32175
[5]
Effect of grapefruit juice on digoxin pharmacokinetics in humans [J].
Becquemont, L ;
Verstuyft, C ;
Kerb, R ;
Brinkmann, U ;
Lebot, M ;
Jaillon, P ;
Funck-Brentano, C .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 70 (04) :311-316
[6]
Halogenated chalcones with high-affinity binding to P-glycoprotein: Potential modulators of multidrug resistance [J].
Bois, F ;
Beney, C ;
Boumendjel, A ;
Mariotte, AM ;
Conseil, G ;
Di Pietro, A .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (21) :4161-4164
[7]
Synthesis and biological activity of 4-alkoxy chalcones: Potential hydrophobic modulators of P-glycoprotein-mediated multidrug resistance [J].
Bois, F ;
Boumendjel, A ;
Mariotte, AM ;
Conseil, G ;
Di Petro, A .
BIOORGANIC & MEDICINAL CHEMISTRY, 1999, 7 (12) :2691-2695
[8]
Antioxidant effects of flavonoids [J].
Bors, W ;
Michel, C ;
Stettmaier, K .
BIOFACTORS, 1997, 6 (04) :399-402
[9]
The chalcone xanthohumol inhibits triglyceride and apolipoprotein B secretion in HepG2 cells [J].
Casaschi, A ;
Maiyoh, GK ;
Rubio, BK ;
Li, RW ;
Adeli, K ;
Theriault, AG .
JOURNAL OF NUTRITION, 2004, 134 (06) :1340-1346
[10]
Transport and epithelial secretion of the cardiac glycoside, digoxin, by human intestinal epithelial (Caco-2) cells [J].
Cavet, ME ;
West, M ;
Simmons, NL .
BRITISH JOURNAL OF PHARMACOLOGY, 1996, 118 (06) :1389-1396